Karen C. Lam

ierian, Inc. developed and manufactured biopharmaceutical products. The firm's lead antibody, IPN007, represents a new approach to treating neurodegenerative disease by targeting a novel form of secreted Tau protein. The company was founded in 2007 and is headquartered in South San Francisco, CA.

Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA.

Kabira Technologies provides communications service providers software applications and performance technology elements that accelerate their Pace of Return by reducing time-to-revenue while lowering overall cost of growth. With installations serving over 700 million subscribers for over 100 customers in more than 40 countries, Kabira has established its reputation for delivering highly scalable and highly reliable solutions. Based on Fluency™, Kabira's powerful transaction platform, Kabira's Policy, Fulfillment and Payments Orchestration product suites are designed to provide essential capabilities that enable service providers to launch services in record time, while creating new ways to monetize their investments. Some of Kabira's customers include AT&T Corp., Orange/France Telecom, Visa, VimpelCom, T-Mobile, Hutchison, Saudi Telecom and NTT. Kabira, Orchestration by Kabira, Policy Orchestration, Fulfillment Orchestration, Payments Orchestration, Fluency, Fluency at the Core and the Kabira logo are registered trademarks, registered service marks or trademarks or service marks of Kabira, and its affiliates, in the United States and certain other countries. All other trademarks are the property of their respective owners.

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA.